Progyny, Inc.

NasdaqGS PGNY

Progyny, Inc. Current Liabilities for the quarter ending September 30, 2024: USD 208.47 M

Progyny, Inc. Current Liabilities is USD 208.47 M for the quarter ending September 30, 2024, a 7.78% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Progyny, Inc. Current Liabilities for the quarter ending September 30, 2023 was USD 193.42 M, a 23.30% change year over year.
  • Progyny, Inc. Current Liabilities for the quarter ending September 30, 2022 was USD 156.87 M, a 50.14% change year over year.
  • Progyny, Inc. Current Liabilities for the quarter ending September 30, 2021 was USD 104.48 M, a 40.88% change year over year.
  • Progyny, Inc. Current Liabilities for the quarter ending September 30, 2020 was USD 74.17 M.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
NasdaqGS: PGNY

Progyny, Inc.

CEO Mr. Peter Anevski CPA
IPO Date Oct. 25, 2019
Location United States
Headquarters 1359 Broadway
Employees 563
Sector Health Care
Industries
Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Similar companies

PRVA

Privia Health Group, Inc.

USD 21.00

1.25%

SLP

Simulations Plus, Inc.

USD 28.76

-0.48%

TDOC

Teladoc Health, Inc.

USD 9.36

-3.50%

EVH

Evolent Health, Inc.

USD 11.18

-9.77%

NRC

National Research Corporation

USD 16.93

-1.97%

CERT

Certara, Inc.

USD 10.74

-2.10%

DH

Definitive Healthcare Corp.

USD 3.92

-0.25%

PHR

Phreesia, Inc.

USD 26.12

-1.69%

HSTM

HealthStream, Inc.

USD 31.47

1.68%

GDRX

GoodRx Holdings, Inc.

USD 4.15

-1.66%

HCAT

Health Catalyst, Inc.

USD 5.90

-9.09%

VEEV

Veeva Systems Inc.

USD 210.86

-0.93%

TXG

10x Genomics, Inc.

USD 15.44

-1.72%

StockViz Staff

January 15, 2025

Any question? Send us an email